42 related articles for article (PubMed ID: 9704729)
21. Antitumor activity of bent metallocenes: electronic structure analysis using DFT computations.
Senthilnathan D; Vaideeswaran S; Venuvanalingam P; Frenking G
J Mol Model; 2011 Mar; 17(3):465-75. PubMed ID: 20495841
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Structure and Biological Activity of Amide-Functionalized Titanocenyls: Improving their Cytotoxic Properties.
Gao LM; Matta J; Rheingold AL; Meléndez E
J Organomet Chem; 2009 Dec; 694(26):4134-4139. PubMed ID: 20177431
[TBL] [Abstract][Full Text] [Related]
23. Spectroscopic and Thermal Characterization of the Host-Guest Interactions between α-, β-, and γ-cyclodextrins and vanadocene dichloride.
Morales A; Weber RT; Melendez E
Appl Organomet Chem; 2008 Jun; 22(8):440-450. PubMed ID: 19881887
[TBL] [Abstract][Full Text] [Related]
24. Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.
Hernández R; Méndez J; Lamboy J; Torres M; Román FR; Meléndez E
Toxicol In Vitro; 2010 Feb; 24(1):178-83. PubMed ID: 19772913
[TBL] [Abstract][Full Text] [Related]
25. Water-soluble molybdenocene complexes with both proliferative and antiproliferative effects on cancer cell lines and their binding interactions with human serum albumin.
Feliciano I; Matta J; Meléndez E
J Biol Inorg Chem; 2009 Sep; 14(7):1109-17. PubMed ID: 19536567
[TBL] [Abstract][Full Text] [Related]
26. A proposed mechanism for the inhibitory effect of the anticancer agent titanocene dichloride on tumour gelatinases and other proteolytic enzymes.
Pavlaki M; Debeli K; Triantaphyllidou IE; Klouras N; Giannopoulou E; Aletras AJ
J Biol Inorg Chem; 2009 Aug; 14(6):947-57. PubMed ID: 19390879
[TBL] [Abstract][Full Text] [Related]
27. Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.
Waern JB; Harris HH; Lai B; Cai Z; Harding MM; Dillon CT
J Biol Inorg Chem; 2005 Aug; 10(5):443-52. PubMed ID: 15906108
[TBL] [Abstract][Full Text] [Related]
28. A hypothesis concerning the relationship of cellular pharmakokinetics to optimal scheduling of anti-cancer agents.
Weiss AJ; Manthei R
Oncology; 1988; 45(6):448-52. PubMed ID: 3054673
[TBL] [Abstract][Full Text] [Related]
29. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Korfel A; Scheulen ME; Schmoll HJ; Gründel O; Harstrick A; Knoche M; Fels LM; Skorzec M; Bach F; Baumgart J; Sass G; Seeber S; Thiel E; Berdel WE
Clin Cancer Res; 1998 Nov; 4(11):2701-8. PubMed ID: 9829732
[TBL] [Abstract][Full Text] [Related]
30. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
Berg SL; Blaney SM; Adamson PC; O'Brien M; Poplack DG; Arndt C; Blatt J; Balis FM
J Clin Oncol; 1998 Jan; 16(1):181-6. PubMed ID: 9440741
[TBL] [Abstract][Full Text] [Related]
31. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
[TBL] [Abstract][Full Text] [Related]
33. Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.
Rinaldi DA; Burris HA; Dorr FA; Woodworth JR; Kuhn JG; Eckardt JR; Rodriguez G; Corso SW; Fields SM; Langley C
J Clin Oncol; 1995 Nov; 13(11):2842-50. PubMed ID: 7595747
[TBL] [Abstract][Full Text] [Related]
34. Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.
Christodoulou CV; Ferry DR; Fyfe DW; Young A; Doran J; Sheehan TM; Eliopoulos A; Hale K; Baumgart J; Sass G; Kerr DJ
J Clin Oncol; 1998 Aug; 16(8):2761-9. PubMed ID: 9704729
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]